Patricia Parris
Trish is a Project Toxicologist in Drug Safety & Metabolism within AstraZeneca and has a background in Genetic Toxicology.
She joined AstraZeneca in 2015 and in addition to managing the non-clinical safety strategy for respiratory and inflammatory disease pharmaceuticals she has a global role providing guidance on all aspects of drug impurity issues.
In recent years, Trish has worked with the ICH M7 sub-group to develop the Addendum table co-authoring the hydrogen peroxide monograph; and the vinyl acetate monograph in the subsequent publication Bercu et al., (2018).
Trish is also the co-chair of the Extractables and Leachables Safety Information Exchange (ELSIE) PDE Sub-team.
